Search Results for: rmat

Recommend reads: CRISPR baby guy free, DNMT3, sperm, Editas, hearing loss, reprogramming

/ / 3 Comments
Dura et al sperm development

We often don’t think of them that way but reproductive cells like sperm and egg are also relatives of stem cells, and it turns out that there are stem cells that make the reproductive cells too like sperm stem cells. Sperm and germ cell stem cells DNMT3A-dependent DNA methylation is required for spermatogonial stem cells […]

Recommend reads: CRISPR baby guy free, DNMT3, sperm, Editas, hearing loss, reprogramming Read More »

Weekly reads: Melton leaves Harvard, Fuji, BBC blunder, stem cell niche, more

/ / Leave a Comment
Senolytics restore the stem cell niche in the brains of mice. Fatt, et al. Stem Cell Reports 2022.

Sometimes a post here on The Niche (named after the stem cell niche) sparks a debate between expert stem cell researchers and often that gives much more depth to a topic. Such was the case with my post this week on where things stand with stem cell therapy for heart disease. It led to a

Weekly reads: Melton leaves Harvard, Fuji, BBC blunder, stem cell niche, more Read More »

Weekly reads: Google, stem cells & MS, VSELs, ‘hairy’ organoids, MYC

/ / Leave a Comment
stem cells differentiating into neurons and glia

It’s been quite a ride doing this blog on stem cells and other technologies for more than a dozen years. So far it seems like I’ll keep it going. A large part of the reason is because of people needing good information about our field. Those people include scientists and physicians but also many in

Weekly reads: Google, stem cells & MS, VSELs, ‘hairy’ organoids, MYC Read More »

FDA news: warning letter pattern, cancer moonshot, CAR-T & gene-editing guidance

/ / Leave a Comment
FDA

The FDA has been busy with the COVID pandemic but it has many other things on its plate as well including cell therapies. Today I’m sharing some recent agency news and brief perspectives on it. FDA focus on clinic-related umbilical cord cell drug makers The agency warned an Idaho company that produces and sells umbilical

FDA news: warning letter pattern, cancer moonshot, CAR-T & gene-editing guidance Read More »

Review of DVC Stem, a clinic marketing of unproven therapies

/ / 14 Comments
DVC Stem video featuring Lou Ferrigno

DVC Stem is an unproven clinic selling stem cells. One notable thing about them is that their website dominates large amounts of Google Search results related to stem cells. This likely drives many new customers to the clinic. The goal of today’s post is to fact check and review DVC Stem. I see reasons for

Review of DVC Stem, a clinic marketing of unproven therapies Read More »

Feds want $3M, prison for Liveyon founder in old fraud case

/ / Leave a Comment
John Kosolcharoen, Liveyon

Before starting the umbilical cord cell supplier and marketing firm Liveyon, John Kosolcharoen was involved in some alleged health care fraud. The feds brought a case against him related to prescription drugs. Older case coming to a head As Liveyon was having its misadventures in the stem cell clinic sphere, the status of that past

Feds want $3M, prison for Liveyon founder in old fraud case Read More »

Stem cell reads: regeneration, 8C, MYC, CRISPR babies

/ / Leave a Comment
wound healing stem cells

Another busy week including on the grant writing treadmill or should I say Mobius strip, but I’m always on the lookout for new reading and this week a lot popped up on regeneration. Also, a paper on healing and scarring. I regularly write about stem cell journals. For a long time, it seems like Cell Stem

Stem cell reads: regeneration, 8C, MYC, CRISPR babies Read More »